NASDAQ
Immuneering Corporation (IMRX) has a fcf yield of -15.71% as of Friday, May 29, 2026. This represents a 57.95% increase compared to its 12-month average of -37.36%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.